financetom
Business
financetom
/
Business
/
Apple to hold fall event on September 9, new iPhones expected
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple to hold fall event on September 9, new iPhones expected
Aug 26, 2025 9:31 AM

(Reuters) -Apple ( AAPL ) said on Tuesday it would host its annual fall event on September 9, when the company is expected to unveil new iPhones, watches and other devices.

The event will be held at the Steve Jobs Theater in Apple Park and serve as a showcase of the company's efforts to integrate artificial intelligence into its devices.

It will be closely watched by investors worried about the company ceding ground to faster-moving rivals in the race to deploy AI technology.

The announcement comes as Apple ( AAPL ) faces pressure from tariffs imposed on U.S. imports from countries including its production hubs of China and India. 

Media reports have said Apple ( AAPL ) will also unveil a slimmer version of its latest iPhone, possibly branded as the iPhone Air, echoing its iPad Air and MacBook Air lines.

The company is also expected to showcase new entry-level, high-end Apple Watches, upgraded iPad Pros and a faster version of the Vision Pro headset, Bloomberg News has reported.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Mar 23, 2026
07:34 AM EDT, 03/23/2026 (MT Newswires) -- Apogee Therapeutics ( APGE ) stock was up 18% pre-bell Monday after the company said that 52-week maintenance data from Part A of its phase two trial of zumilokibart in patients with moderate-to-severe atopic dermatitis demonstrated durable maintenance response and deepening response for lesional and itch endpoints. Indivior (INDV) shares were 13% higher...
Pfizer, Valneva Say Potential Lyme Disease Vaccine Reduces Infection by Over 73% in Phase 3 Study
Pfizer, Valneva Say Potential Lyme Disease Vaccine Reduces Infection by Over 73% in Phase 3 Study
Mar 23, 2026
07:34 AM EDT, 03/23/2026 (MT Newswires) -- Pfizer ( PFE ) and Valneva (VALN) said Monday that their investigational vaccine candidate LB6V against outdoor Lyme disease reduced the rate of confirmed cases by 73.2% compared with placebo in a phase 3 clinical study. The efficacy result came 28 days after the fourth dose in the second season of the study,...
Diversis Capital Acquires LTi Technology Solutions to Accelerate Innovation in Equipment Finance Technology
Diversis Capital Acquires LTi Technology Solutions to Accelerate Innovation in Equipment Finance Technology
Mar 23, 2026
OMAHA, Neb., March 23, 2026 /PRNewswire/ -- LTi Technology Solutions (LTi), a global leader in software for the equipment finance industry, today announced it has been acquired by Diversis Capital, L.P. (Diversis), a Los Angeles-based private equity firm focused on building and scaling high-growth software and technology-enabled services companies. Founded in 1989, LTi has spent more than three decades developing...
Viatris Says Japan Regulator Approves Effexor for Generalized Anxiety Disorder in Adults
Viatris Says Japan Regulator Approves Effexor for Generalized Anxiety Disorder in Adults
Mar 23, 2026
07:34 AM EDT, 03/23/2026 (MT Newswires) -- Viatris ( VTRS ) said Monday that Japan's Ministry of Health, Labour and Welfare has approved Effexor as a treatment for adults with generalized anxiety disorder. The company said the approval was based on a phase 3 study in Japan, which met its primary and secondary endpoints. Effexor, or venlafaxine hydrochloride, was earlier...
Copyright 2023-2026 - www.financetom.com All Rights Reserved